메뉴 건너뛰기




Volumn 55, Issue 21 SUPPL., 1998, Pages

Pharmacology and clinical efficacy of cholinesterase inhibitors

Author keywords

Alzheimer's disease; Clinical studies; Donepezil; Drug comparisons; Drugs, clinical effectiveness; Parasympathomimetic agents; Pharmacokinetics; Physostigmine; Rivastigmine; Tacrine; Toxicity; Trichlorf on

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; METRIFONATE; PHYSOSTIGMINE; RIVASTIGMINE; TACRINE; UNCLASSIFIED DRUG;

EID: 0032213644     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/55.suppl_2.s22     Document Type: Conference Paper
Times cited : (26)

References (22)
  • 1
    • 0030976004 scopus 로고    scopus 로고
    • Cognitive enhancement therapy for Alzheimer's disease: The way forward
    • Parnetti L, Senin U, Mecocci P. Cognitive enhancement therapy for Alzheimer's disease: the way forward. Drugs 1997; 53:752-68.
    • (1997) Drugs , vol.53 , pp. 752-768
    • Parnetti, L.1    Senin, U.2    Mecocci, P.3
  • 2
    • 0029917179 scopus 로고    scopus 로고
    • Safety/tolerability trial of SDZ ENA 713 in patients with probable Alzheimer's disease
    • Sramek JJ, Anand R, Wardle TS et al. Safety/tolerability trial of SDZ ENA 713 in patients with probable Alzheimer's disease. Life Sci. 1996; 58:1201-7.
    • (1996) Life Sci. , vol.58 , pp. 1201-1207
    • Sramek, J.J.1    Anand, R.2    Wardle, T.S.3
  • 3
    • 0028448282 scopus 로고
    • Tacrine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease
    • Wagstaff AJ, McTavish D. Tacrine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease. Drugs Aging. 1994; 4:510-40.
    • (1994) Drugs Aging , vol.4 , pp. 510-540
    • Wagstaff, A.J.1    McTavish, D.2
  • 4
    • 0031904626 scopus 로고    scopus 로고
    • Alzheimer's disease: Clinical features and pharmacologic management
    • Franks AS, Rawls WN. Alzheimer's disease: clinical features and pharmacologic management. Am J Manag Care. 1998; 4:595-604.
    • (1998) Am J Manag Care , vol.4 , pp. 595-604
    • Franks, A.S.1    Rawls, W.N.2
  • 5
    • 0013163515 scopus 로고    scopus 로고
    • New York: Roerig, Division of Pfizer, Inc.
    • Aricept package insert. New York: Roerig, Division of Pfizer, Inc.; 1996.
    • (1996) Aricept Package Insert
  • 6
    • 0027141935 scopus 로고
    • Comparison of the pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy young and elderly subjects
    • Ohnishi A, Mihara M, Kamakura H et al. Comparison of the pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy young and elderly subjects. J Clin Pharmacol. 1993; 33:1086-91.
    • (1993) J Clin Pharmacol. , vol.33 , pp. 1086-1091
    • Ohnishi, A.1    Mihara, M.2    Kamakura, H.3
  • 7
    • 0029915565 scopus 로고    scopus 로고
    • Metrifonate induces cholinesterase inhibition exclusively via slow release of dichlorvos
    • Hinz VC, Grewig S, Schmidt BH. Metrifonate induces cholinesterase inhibition exclusively via slow release of dichlorvos. Neurochem Res. 1996; 21:331-7.
    • (1996) Neurochem Res. , vol.21 , pp. 331-337
    • Hinz, V.C.1    Grewig, S.2    Schmidt, B.H.3
  • 8
    • 0021520020 scopus 로고
    • A new rating scale for Alzheimer's disease
    • Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry. 1984; 141:1356-64.
    • (1984) Am J Psychiatry , vol.141 , pp. 1356-1364
    • Rosen, W.G.1    Mohs, R.C.2    Davis, K.L.3
  • 9
    • 0024246154 scopus 로고
    • Alzheimer's Disease Assessment Scale (ADAS)
    • Mohs RC, Cohen L. Alzheimer's Disease Assessment Scale (ADAS). Psychopharmacol Bull. 1988; 24:627-8.
    • (1988) Psychopharmacol Bull. , vol.24 , pp. 627-628
    • Mohs, R.C.1    Cohen, L.2
  • 10
    • 0028114429 scopus 로고
    • The Clinician Interview-Based Impression (CIBI): A clinician's global change rating scale in Alzheimer's disease
    • Knopman DS, Knapp MJ, Gracon SI et al. The Clinician Interview-Based Impression (CIBI): a clinician's global change rating scale in Alzheimer's disease. Neurology. 1994; 44:2315-21.
    • (1994) Neurology , vol.44 , pp. 2315-2321
    • Knopman, D.S.1    Knapp, M.J.2    Gracon, S.I.3
  • 11
    • 0016823810 scopus 로고
    • "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician
    • Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12:189-98.
    • (1975) J Psychiatr Res. , vol.12 , pp. 189-198
    • Folstein, M.F.1    Folstein, S.E.2    McHugh, P.R.3
  • 12
    • 0026792979 scopus 로고
    • A controlled trial of tacrine in Alzheimer's disease
    • The Tacrine Study Group
    • Farlow M, Gracon SI, Hershey LA et al. A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group. JAMA. 1992; 268:2523-9.
    • (1992) JAMA , vol.268 , pp. 2523-2529
    • Farlow, M.1    Gracon, S.I.2    Hershey, L.A.3
  • 13
    • 10244259208 scopus 로고    scopus 로고
    • The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trial
    • The Donepezil Study Group
    • Rogers SL, Friedhoff LT. The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US multicentre, randomized, double-blind, placebo-controlled trial. The Donepezil Study Group. Dementia. 1996; 7:293-303.
    • (1996) Dementia , vol.7 , pp. 293-303
    • Rogers, S.L.1    Friedhoff, L.T.2
  • 14
    • 0032513106 scopus 로고    scopus 로고
    • Safety and tolerability of metrifonate in patients with Alzheimer's disease: Results of a maximum tolerated dose study
    • Cutler NR, Jhee SS, Cyrus P et al. Safety and tolerability of metrifonate in patients with Alzheimer's disease: results of a maximum tolerated dose study. Life Sci. 1998; 62:1433-41.
    • (1998) Life Sci. , vol.62 , pp. 1433-1441
    • Cutler, N.R.1    Jhee, S.S.2    Cyrus, P.3
  • 15
    • 0031883716 scopus 로고    scopus 로고
    • A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
    • Rogers SL, Farlow MR, Doody RS et al. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology. 1998; 50:136-45.
    • (1998) Neurology , vol.50 , pp. 136-145
    • Rogers, S.L.1    Farlow, M.R.2    Doody, R.S.3
  • 16
    • 0029766994 scopus 로고    scopus 로고
    • Efficacy and safety results of the early phase studies with Exelon (ENA-713) in Alzheimer's disease: An overview
    • Anand R, Gharabawi G, Enz A. Efficacy and safety results of the early phase studies with Exelon (ENA-713) in Alzheimer's disease: an overview. J Drug Dev Clin Pract. 1996; 8:109-16.
    • (1996) J Drug Dev Clin Pract. , vol.8 , pp. 109-116
    • Anand, R.1    Gharabawi, G.2    Enz, A.3
  • 17
    • 0031842292 scopus 로고    scopus 로고
    • Metrifonate treatment of the cognitive deficits of Alzheimer's disease
    • Cummings JL, Cyrus PA, Bieber F et al. Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Neurology. 1998; 50:1214-21.
    • (1998) Neurology , vol.50 , pp. 1214-1221
    • Cummings, J.L.1    Cyrus, P.A.2    Bieber, F.3
  • 21
    • 0029914548 scopus 로고    scopus 로고
    • Effect of tacrine on behavioral symptoms in Alzheimer's disease: An open-label study
    • Kaufer DI, Cummings JL, Christine D. Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study. J Geriatr Psychiatry Neurol. 1996; 9:1-6.
    • (1996) J Geriatr Psychiatry Neurol. , vol.9 , pp. 1-6
    • Kaufer, D.I.1    Cummings, J.L.2    Christine, D.3
  • 22
    • 0001033736 scopus 로고    scopus 로고
    • The efficacy of metrifonate in improving the behavioral disturbances of Alzheimer's disease patients
    • Minneapolis; Apr 25-May 3
    • Cummings JL, Cyrus PA, Ruzicka BB et al. The efficacy of metrifonate in improving the behavioral disturbances of Alzheimer's disease patients. Paper presented at American Academy of Neurology 1998 Annual Meeting. Minneapolis; 1998 Apr 25-May 3.
    • (1998) American Academy of Neurology 1998 Annual Meeting
    • Cummings, J.L.1    Cyrus, P.A.2    Ruzicka, B.B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.